American Century Companies Inc. Has $3.38 Million Position in Omnicell, Inc. $OMCL

American Century Companies Inc. trimmed its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL) by 37.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 115,103 shares of the company’s stock after selling 69,712 shares during the quarter. American Century Companies Inc.’s holdings in Omnicell were worth $3,384,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. GAMMA Investing LLC increased its holdings in Omnicell by 37.1% in the second quarter. GAMMA Investing LLC now owns 1,694 shares of the company’s stock valued at $50,000 after purchasing an additional 458 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in shares of Omnicell in the 2nd quarter valued at about $210,000. AlphaQuest LLC increased its stake in shares of Omnicell by 79.0% in the first quarter. AlphaQuest LLC now owns 6,400 shares of the company’s stock valued at $224,000 after buying an additional 2,824 shares during the period. EntryPoint Capital LLC increased its stake in shares of Omnicell by 21.6% in the first quarter. EntryPoint Capital LLC now owns 6,671 shares of the company’s stock valued at $233,000 after buying an additional 1,184 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its position in shares of Omnicell by 7.4% during the second quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,040 shares of the company’s stock worth $236,000 after acquiring an additional 552 shares during the last quarter. 97.70% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Corey J. Manley sold 3,880 shares of the firm’s stock in a transaction that occurred on Friday, September 12th. The shares were sold at an average price of $33.25, for a total transaction of $129,010.00. Following the completion of the sale, the executive vice president owned 110,653 shares in the company, valued at $3,679,212.25. This trade represents a 3.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 2.52% of the company’s stock.

Wall Street Analyst Weigh In

OMCL has been the topic of a number of recent analyst reports. Piper Sandler dropped their price target on shares of Omnicell from $57.00 to $55.00 and set an “overweight” rating on the stock in a research report on Monday, August 11th. Weiss Ratings restated a “sell (d+)” rating on shares of Omnicell in a report on Wednesday, October 8th. Finally, Benchmark upped their price target on shares of Omnicell from $40.00 to $45.00 and gave the company a “buy” rating in a research report on Friday, October 31st. Three investment analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $42.00.

Omnicell Trading Up 7.6%

NASDAQ OMCL opened at $43.55 on Tuesday. The company has a current ratio of 1.44, a quick ratio of 1.21 and a debt-to-equity ratio of 0.14. The business has a fifty day simple moving average of $33.72 and a 200 day simple moving average of $31.57. Omnicell, Inc. has a 12 month low of $22.66 and a 12 month high of $47.82. The firm has a market capitalization of $1.95 billion, a P/E ratio of 101.28, a PEG ratio of 5.01 and a beta of 0.83.

About Omnicell

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.